Profile data is unavailable for this security.
About the company
ExpreS2ion Biotech Holding AB is a Sweden-based biopharmaceutical company. The Company specializes in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system. The Company's ExpreS2 recombinant protein expression platform supports all phases of drug discovery, research and development and manufacturing. ExpreS2 is a non-viral insect cell expression system that establishes stable polyclonal pools that provide high-protein expression levels without selection pressure. The system is designed for transient or stable transfections using vector deoxyribonucleic acid containing a hybrid promoter. It also ensures high cell density without aggregation or toxic metabolite build-up issues. Through the joint venture AdaptVac ApS, the Company applies a Plug-and-Play Virus Like Particle technology for development of therapeutic and prophylactic vaccines within oncology, infectious diseases and immunological disorders.
- Revenue in SEK (TTM)7.77m
- Net income in SEK-77.95m
- Incorporated2015
- Employees18.00
- LocationExpreS2ion Biotech Holding ABRonnowsgatan 8 CHELSINGBORG 25225SwedenSWE
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
XP Chemistries AB | 443.13k | -7.84m | 16.44m | 2.00 | -- | 0.6898 | -- | 37.11 | -0.2479 | -0.2479 | 0.0098 | 0.2552 | 0.0164 | 3.25 | 18.68 | 221,565.00 | -29.04 | -- | -30.83 | -- | -1,116.68 | -- | -1,769.29 | -- | 4.72 | -- | 0.00 | -- | -37.14 | -- | -1.55 | -- | -- | -- |
Redwood Pharma AB | 0.00 | -13.60m | 24.10m | 1.00 | -- | 0.3564 | -- | -- | -5.87 | -5.87 | 0.00 | 3.18 | 0.00 | -- | -- | 0.00 | -106.53 | -95.03 | -121.24 | -123.04 | -- | -- | -- | -- | -- | -19.12 | 0.00 | -- | -- | -- | -8.78 | -- | -5.11 | -- |
Lipigon Pharmaceuticals AB | 16.41m | -12.71m | 40.46m | -- | -- | 1.89 | -- | 2.47 | -0.2459 | -0.2459 | 0.2138 | 0.1694 | 1.07 | -- | 21.49 | -- | -83.21 | -314.67 | -137.73 | -426.49 | -- | -- | -77.44 | -488.14 | -- | -- | 0.00 | -- | -- | 444.44 | 67.83 | -- | -- | -- |
Oncozenge AB | 0.00 | -14.22m | 53.35m | -- | -- | 3.28 | -- | -- | -1.21 | -1.21 | 0.00 | 1.39 | 0.00 | -- | -- | -- | -58.23 | -- | -61.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 65.91 | -- | -- | -- |
Lipidor AB | 87.00k | -11.59m | 57.74m | -- | -- | -- | -- | 663.67 | -0.1049 | -0.1049 | 0.0008 | -0.0817 | 0.0122 | -- | 0.19 | -- | -162.65 | -59.41 | -- | -75.10 | -- | -- | -13,322.99 | -643.36 | -- | -- | -- | -- | 73.33 | -20.33 | 72.24 | -- | -- | -- |
Elicera Therapeutics AB | 12.85m | -19.50m | 72.99m | 2.00 | -- | 2.31 | -- | 5.68 | -0.9726 | -0.9726 | 0.6416 | 0.901 | 0.3015 | -- | 11.43 | 6,426,955.00 | -45.75 | -40.06 | -62.75 | -49.74 | -- | -- | -151.72 | -415.41 | -- | -- | 0.00 | -- | 777.23 | -- | 15.64 | -- | -- | -- |
ExpreS2ion Biotech Holding AB | 7.77m | -77.95m | 77.19m | 18.00 | -- | 1.06 | -- | 9.94 | -1.33 | -1.33 | 0.129 | 0.8696 | 0.0821 | -- | 4.87 | 298,730.80 | -82.36 | -63.54 | -113.92 | -75.88 | -132.91 | -1.94 | -1,003.55 | -524.31 | -- | -- | 0.0055 | -- | 43.07 | -0.1561 | 22.94 | -- | 19.90 | -- |
Odi Pharma AB (publ) | 14.80m | -1.67m | 86.75m | -- | -- | 24.86 | -- | 5.86 | -0.1097 | -0.1097 | 0.9727 | 0.2293 | 1.36 | 18.13 | 3.94 | -- | -15.36 | -- | -39.25 | -- | -25.26 | -- | -11.27 | -- | 1.26 | -2.31 | 0.00 | -- | -55.44 | -- | 4.67 | -- | -- | -- |
Ziccum AB | 6.64m | -20.50m | 89.55m | 9.00 | -- | 6.59 | -- | 13.50 | -1.46 | -1.46 | 0.4721 | 0.8534 | 0.2696 | -- | 22.01 | 829,375.00 | -83.29 | -68.51 | -106.42 | -76.47 | -- | -- | -308.94 | -2,598.03 | -- | -- | 0.0516 | -- | -- | 75.20 | 25.62 | -- | -13.45 | -- |
StenoCare A/S | 6.46m | -26.46m | 115.20m | 9.00 | -- | 2.97 | -- | 17.83 | -1.13 | -1.13 | 0.2674 | 1.22 | 0.1285 | -- | 2.94 | -- | -52.62 | -28.16 | -70.34 | -35.47 | -- | -- | -409.55 | -371.06 | 1.04 | -5.56 | 0.2362 | -- | -16.30 | -- | -7.77 | -- | -- | -- |
Pila Pharma AB | 1.46m | -9.93m | 122.30m | 1.00 | -- | 18.36 | -- | 83.59 | -0.5304 | -0.5304 | 0.0767 | 0.28 | 0.1513 | -- | 6.11 | 1,463,020.00 | -102.68 | -108.88 | -122.66 | -121.45 | -127.88 | -42.67 | -678.73 | -1,577.64 | -- | -159.47 | 0.104 | -- | -22.21 | -- | 62.92 | -- | -- | -- |
Vivesto AB | 0.00 | -116.73m | 145.00m | 6.00 | -- | 0.7657 | -- | -- | -0.219 | -0.219 | 0.00 | 0.352 | 0.00 | -- | -- | 0.00 | -44.08 | -- | -47.15 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | 64.80 | -- | -- | -- |
Lipum AB (publ) | 0.00 | -39.32m | 216.37m | 5.00 | -- | -- | -- | -- | -4.44 | -4.44 | 0.00 | -0.49 | 0.00 | -- | -- | 0.00 | -247.63 | -127.85 | -402.13 | -184.50 | -- | -- | -- | -293,228.70 | -- | -- | -- | -- | -- | -- | 2.38 | -- | -- | -- |